Your shopping cart is currently empty

HPK1-IN-35 is a potent, selective inhibitor of HPK1, demonstrating an IC50 value of 3.5 nM. This compound reduces p-SLP76 expression and facilitates the secretion of IL-2 [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 8-10 weeks | 8-10 weeks | |
| 50 mg | $1,980 | 8-10 weeks | 8-10 weeks | |
| 100 mg | $2,500 | 8-10 weeks | 8-10 weeks |
| Description | HPK1-IN-35 is a potent, selective inhibitor of HPK1, demonstrating an IC50 value of 3.5 nM. This compound reduces p-SLP76 expression and facilitates the secretion of IL-2 [1]. |
| Targets&IC50 | HPK1:3.5 nM |
| In vitro | HPK1-IN-35 (compound 31) reduces anti-CD3 antibody (1 µg/mL)-stimulated p-SLP76 expression dose-dependently at concentrations of 0.1, 0.3, 1, and 3 µM after 1 hour of treatment [1]. Furthermore, HPK1-IN-35 enhances IL-2 secretion from Jurkat cells in a dose-dependent manner within the range of 0-10 µM over 24 hours, with an EC50 value of 1.19 µM [1]. |
| Molecular Weight | 584.69 |
| Formula | C30H32N8O3S |
| Cas No. | 2935903-77-6 |
| Smiles | N(C1=C2C(=CNC2=NC(NC3=C(OC)C=C4C(=C3)CN(C)CC4)=N1)C=5C=CC=NC5)C6=C(S(N(C)C)(=O)=O)C=CC=C6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.